Entry - #613690 - CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7 - OMIM
# 613690

CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
19q13.42 Cardiomyopathy, hypertrophic, 7 613690 AD 3 TNNI3 191044
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
CARDIOVASCULAR
Heart
- Ventricular hypertrophy
- Apical hypertrophy (in some patients)
- Ventricular preexcitation, Wolff-Parkinson-White (in some patients)
- Atrial fibrillation (in some patients)
MISCELLANEOUS
- Genetic heterogeneity (see 192600)
- Sudden cardiac death in some families
MOLECULAR BASIS
- Caused by mutation in the cardiac troponin I gene (TNNI3, 191044.0001)
Cardiomyopathy, familial hypertrophic - PS192600 - 37 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p31.1 Cardiomyopathy, hypertrophic, 20 AD 3 613876 NEXN 613121
1q32.1 Cardiomyopathy, hypertrophic, 2 AD 3 115195 TNNT2 191045
1q43 Cardiomyopathy, dilated, 1AA, with or without LVNC AD 3 612158 ACTN2 102573
1q43 Cardiomyopathy, hypertrophic, 23, with or without LVNC AD 3 612158 ACTN2 102573
2q31.2 Cardiomyopathy, familial hypertrophic, 9 AD 3 613765 TTN 188840
3p25.3 Cardiomyopathy, familial hypertrophic AD, DD 3 192600 CAV3 601253
3p21.31 Cardiomyopathy, hypertrophic, 8 AD, AR 3 608751 MYL3 160790
3p21.1 Cardiomyopathy, hypertrophic, 13 AD 3 613243 TNNC1 191040
3q27.1 Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies AR 3 620236 KLHL24 611295
4p12 ?Cardiomyopathy, familial hypertrophic, 30, atrial AR 3 620734 CORIN 605236
4q26 Cardiomyopathy, hypertrophic, 16 AD 3 613838 MYOZ2 605602
6q22.31 Cardiomyopathy, hypertrophic, 18 AD 3 613874 PLN 172405
7p12.1-q21 Cardiomyopathy, hypertrophic, 21 AD 2 614676 CMH21 614676
7q32.1 Cardiomyopathy, familial restrictive 5 AD 3 617047 FLNC 102565
7q32.1 Arrhythmogenic right ventricular dysplasia, familial AD 3 617047 FLNC 102565
7q32.1 Cardiomyopathy, familial hypertrophic, 26 AD 3 617047 FLNC 102565
7q36.1 Cardiomyopathy, hypertrophic 6 AD 3 600858 PRKAG2 602743
10q21.3 Cardiomyopathy, familial restrictive, 4 AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, hypertrophic, 22 AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, dilated, 1KK AD 3 615248 MYPN 608517
10q22.2 Cardiomyopathy, hypertrophic, 15 AD 3 613255 VCL 193065
10q23.2 Left ventricular noncompaction 3 AD 3 601493 LDB3 605906
10q23.2 Cardiomyopathy, dilated, 1C, with or without LVNC AD 3 601493 LDB3 605906
10q23.2 Cardiomyopathy, hypertrophic, 24 AD 3 601493 LDB3 605906
11p15.1 Cardiomyopathy, hypertrophic, 12 AD 3 612124 CSRP3 600824
11p11.2 Cardiomyopathy, hypertrophic, 4 AD, AR 3 115197 MYBPC3 600958
12q24.11 Cardiomyopathy, hypertrophic, 10 AD 3 608758 MYL2 160781
14q11.2 Cardiomyopathy, hypertrophic, 14 AD 3 613251 MYH6 160710
14q11.2 Cardiomyopathy, hypertrophic, 1 AD, DD 3 192600 MYH7 160760
15q14 Cardiomyopathy, hypertrophic, 11 AD 3 612098 ACTC1 102540
15q22.2 Cardiomyopathy, hypertrophic, 3 AD 3 115196 TPM1 191010
15q25.3 Cardiomyopathy, familial hypertrophic 27 AR 3 618052 ALPK3 617608
17q12 Cardiomyopathy, hypertrophic, 25 AD 3 607487 TCAP 604488
18q12.2 Cardiomyopathy, familial hypertrophic, 28 AD 3 619402 FHOD3 609691
19q13.42 Cardiomyopathy, hypertrophic, 7 AD 3 613690 TNNI3 191044
20q11.21 Cardiomyopathy, hypertrophic, 1, digenic AD, DD 3 192600 MYLK2 606566
20q13.12 Cardiomyopathy, hypertrophic, 17 AD 3 613873 JPH2 605267

TEXT

A number sign (#) is used with this entry because of evidence that familial hypertrophic cardiomyopathy-7 (CMH7) is caused by heterozygous mutation in the TNNI3 gene (191044) on chromosome 19q13.

For a general phenotypic description and a discussion of genetic heterogeneity of familial hypertrophic cardiomyopathy (CMH), see CMH1 (192600).


Clinical Features

Kimura et al. (1997) identified 6 probands with hypertrophic cardiomyopathy and mutations in the TNNI3 gene. Three of these probands had ventricular hypertrophy characteristic of CMH; 3 others had apical hypertrophy (so-called Japanese-type CMH). The mutation-carrying son of one proband with apical hypertrophy had typical CMH. The 3 patients with apical hypertrophy carrying a G203S mutation (191044.0014) also exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200).

Niimura et al. (2002) presented data from a genetic analysis of 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history. They identified 2 individuals with CMH7. The mean age of symptom development was 52.5 +/- 3.6 with a mean age at diagnosis of 49.0 +/- 9.9.

Arad et al. (2005) identified a proband with CMH7 with atrial fibrillation and apical cardiac hypertrophy. Five family members had undergone sudden cardiac death, and 3 additional mutation carriers in the family were found to have other CMH morphologies. In another family with the same mutation, the phenotype was primarily subaortic asymmetric hypertrophy.


Inheritance

The transmission pattern of CMH7 in the families reported by Kimura et al. (1997) was consistent with autosomal dominant inheritance.


Molecular Genetics

Kimura et al. (1997) analyzed the TNNI3 gene in 184 unrelated patients with CMH and identified 6 heterozygous mutations in 6 probands, respectively (see, e.g., 191044.0001 and 191044.0002). Although apical CMH had been associated particularly with CMH4 (115197), Kimura et al. (1997) found that 3 of 36 (8.3%) patients with apical CMH had mutations in the TNNI3 gene. In addition, all 3 individuals with the G203S mutation in the TNNI3 gene (191044.0014) exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200); Kimura et al. (1997) noted that although a locus for 'CMH with WPW' had been mapped to chromosome 7q3 (CMH6; 600858), their findings indicated that more than one form of CMH is associated with WPW syndrome.

Among 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history, Niimura et al. (2002) identified 2 individuals with pathogenic mutations in the TNNI3 gene. Both reported mutations (191044.0003, 191044.0004) were missense mutations in conserved residues.

Arad et al. (2005) identified a heterozygous R21C mutation in the TNNI3 gene (191044.0016) in 2 families with CMH.


REFERENCES

  1. Arad, M., Penas-Lado, M., Monserrat, L., Maron, B. J., Sherrid, M., Ho, C. Y., Barr, S., Karim, A., Olson, T. M., Kamisago, M., Seidman, J. G., Seidman, C. E. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112: 2805-2811, 2005. [PubMed: 16267253, related citations] [Full Text]

  2. Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., Koyanagi, T., Hwang, T.-H., Choo, J., Chung, K.-S., Hasegawa, A., Nagai, R., Okazaki, O., Nakamura, H., Matsuzaki, M., Sakamoto, T., Toshima, H., Koga, Y., Imaizumi, T., Sasazuki, T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet. 16: 379-382, 1997. [PubMed: 9241277, related citations] [Full Text]

  3. Niimura, H., Patton, K. K., McKenna, W. J., Soults, J., Maron, B. J., Seidman, J. G., Seidman, C. E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105: 446-451, 2002. [PubMed: 11815426, related citations] [Full Text]


Creation Date:
Anne M. Stumpf : 1/13/2011
carol : 12/15/2022
carol : 09/22/2020
alopez : 01/14/2011
alopez : 1/14/2011
alopez : 1/14/2011

# 613690

CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7


DO: 0110313;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
19q13.42 Cardiomyopathy, hypertrophic, 7 613690 Autosomal dominant 3 TNNI3 191044

TEXT

A number sign (#) is used with this entry because of evidence that familial hypertrophic cardiomyopathy-7 (CMH7) is caused by heterozygous mutation in the TNNI3 gene (191044) on chromosome 19q13.

For a general phenotypic description and a discussion of genetic heterogeneity of familial hypertrophic cardiomyopathy (CMH), see CMH1 (192600).


Clinical Features

Kimura et al. (1997) identified 6 probands with hypertrophic cardiomyopathy and mutations in the TNNI3 gene. Three of these probands had ventricular hypertrophy characteristic of CMH; 3 others had apical hypertrophy (so-called Japanese-type CMH). The mutation-carrying son of one proband with apical hypertrophy had typical CMH. The 3 patients with apical hypertrophy carrying a G203S mutation (191044.0014) also exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200).

Niimura et al. (2002) presented data from a genetic analysis of 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history. They identified 2 individuals with CMH7. The mean age of symptom development was 52.5 +/- 3.6 with a mean age at diagnosis of 49.0 +/- 9.9.

Arad et al. (2005) identified a proband with CMH7 with atrial fibrillation and apical cardiac hypertrophy. Five family members had undergone sudden cardiac death, and 3 additional mutation carriers in the family were found to have other CMH morphologies. In another family with the same mutation, the phenotype was primarily subaortic asymmetric hypertrophy.


Inheritance

The transmission pattern of CMH7 in the families reported by Kimura et al. (1997) was consistent with autosomal dominant inheritance.


Molecular Genetics

Kimura et al. (1997) analyzed the TNNI3 gene in 184 unrelated patients with CMH and identified 6 heterozygous mutations in 6 probands, respectively (see, e.g., 191044.0001 and 191044.0002). Although apical CMH had been associated particularly with CMH4 (115197), Kimura et al. (1997) found that 3 of 36 (8.3%) patients with apical CMH had mutations in the TNNI3 gene. In addition, all 3 individuals with the G203S mutation in the TNNI3 gene (191044.0014) exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200); Kimura et al. (1997) noted that although a locus for 'CMH with WPW' had been mapped to chromosome 7q3 (CMH6; 600858), their findings indicated that more than one form of CMH is associated with WPW syndrome.

Among 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history, Niimura et al. (2002) identified 2 individuals with pathogenic mutations in the TNNI3 gene. Both reported mutations (191044.0003, 191044.0004) were missense mutations in conserved residues.

Arad et al. (2005) identified a heterozygous R21C mutation in the TNNI3 gene (191044.0016) in 2 families with CMH.


REFERENCES

  1. Arad, M., Penas-Lado, M., Monserrat, L., Maron, B. J., Sherrid, M., Ho, C. Y., Barr, S., Karim, A., Olson, T. M., Kamisago, M., Seidman, J. G., Seidman, C. E. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112: 2805-2811, 2005. [PubMed: 16267253] [Full Text: https://doi.org/10.1161/CIRCULATIONAHA.105.547448]

  2. Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., Koyanagi, T., Hwang, T.-H., Choo, J., Chung, K.-S., Hasegawa, A., Nagai, R., Okazaki, O., Nakamura, H., Matsuzaki, M., Sakamoto, T., Toshima, H., Koga, Y., Imaizumi, T., Sasazuki, T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet. 16: 379-382, 1997. [PubMed: 9241277] [Full Text: https://doi.org/10.1038/ng0897-379]

  3. Niimura, H., Patton, K. K., McKenna, W. J., Soults, J., Maron, B. J., Seidman, J. G., Seidman, C. E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105: 446-451, 2002. [PubMed: 11815426] [Full Text: https://doi.org/10.1161/hc0402.102990]


Creation Date:
Anne M. Stumpf : 1/13/2011

Edit History:
carol : 12/15/2022
carol : 09/22/2020
alopez : 01/14/2011
alopez : 1/14/2011
alopez : 1/14/2011